We are live on ! Find out more
ERB

ERBA DIAGNOSTICS
ERB

Delisted

ERB was delisted on the 29th of September, 2016.

15 hedge funds and large institutions have $1.52M invested in ERBA DIAGNOSTICS in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

7% more funds holding

Funds holding: 1415 (+1)

22% less capital invested

Capital invested by funds: $1.94M → $1.52M (-$418K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ERB Hedge Fund Activity: Q2 2014 in Review

15 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in ERBA DIAGNOSTICS (ERB) for Q2 2014, worth a combined $1.52M — down 22% from $1.94M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ERB positions and 4 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $53.2K. The largest seller was Renaissance Technologies, cutting an estimated $55.4K.

  • 15 institutional investors held ERBA DIAGNOSTICS (ERB) as of Q2 2014, up from 14 in Q1 2014.
  • Funds reported $1.52M of ERBA DIAGNOSTICS stock for Q2 2014, down 22% quarter-over-quarter.
  • 5 funds opened new ERBA DIAGNOSTICS positions in Q2 2014 and 4 closed out, a net change of +1 holder.
  • The largest ERBA DIAGNOSTICS buyer in Q2 2014 was Vanguard Group, an estimated $53.2K added.
  • The largest ERBA DIAGNOSTICS seller in Q2 2014 was Renaissance Technologies, an estimated $55.4K sold.

Based on aggregated 13F filings for Q2 2014.